Self-fused concatenation of interferon with enhanced bioactivity, pharmacokinetics and antitumor efficacy
RSC ADVANCES(2022)
Abstract
We report an easy but universal protein modification approach, self-fused concatenation (SEC), to biosynthesize a set of interferon (IFN) concatemers with improved in vitro bioactivity, in vivo pharmacokinetics and therapeutic efficacy over the monomeric IFN, and the results can be positively enhanced by the concatenated number of self-fused proteins.
MoreTranslated text
Key words
interferon,concatenation,antitumor efficacy,enhanced bioactivity,self-fused
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined